"Designing Growth Strategies is in our DNA"

U.S. Vaccines Market Size, Share & COVID-19 Impact Analysis, By Type (Live Attenuated, mRNA, Viral Vectors, Toxoid, and Others), By Route of Administration (Parenteral and Oral), By Disease Indication (Viral Diseases {Hepatitis, Influenza, Human Papillomavirus, Herpes Zoster, and Others}, and Bacterial Diseases {Meningococcal Disease, Pneumococcal Disease and Others}), By Age Group (Pediatrics and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Country Forecast, 2023-2030

Last Updated: January 27, 2025 | Format: PDF | Report ID: FBI109196

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2024

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 8.2% from 2023 to 2030

Unit

Value (USD Billion)

Segmentation

By Type

  • Recombinant/Conjugate/Subunit
  • Inactivated
  • Live attenuated
  • mRNA
  • Viral Vectors
  • Toxoid
  • Others

By Route of Administration

  • Parenteral
  • Oral

By Disease Indication

  • Viral Diseases
    • Hepatitis
    • Influenza
    • Human Papillomavirus
    • Measles/Mumps/Rubella
    • Rotavirus
    • Herpes Zoster
    • Others
  • Bacterial Diseases
    • Meningococcal Disease
    • Pneumococcal Disease
    • Diphtheria/Tetanus/Pertussis
    • Others

By Age Group

  • Pediatrics
  • Adults

By Distribution Channel

  • Hospital & Retail Pharmacies
  • Government Suppliers
  • Others
  • 2019-2030
  • 2022
  • 2019-2021
  • 90
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase